India's First mRNA COVID Vaccine Candidate Found To Be Safe, Gets DCGI Nod For Phase 2/3 Clinical Trials
Indian Drug Regulator's Expert Panel Recommends Phase 1 Trial Of Bharat Biotech's Intranasal Covid-19 Vaccine
